
Baofa Yu, MD Madaxa Dhakhaatiirta Shiinaha, Professor Adjunct ee Jaamacadda Texas (El Paso) (2016) iyo Professor Adjunct ee Jaamacadda Galbeedka Sayniska Caafimaadka (2016). Waxa uu ka qalin jabiyay kuliyada caafimaadka ee Peking Union (Peking Union Medical College) sanadkii 1988. Waxa uu ahaa dhakhtar post-doctoral at UCSD laga bilaabo 1990 ilaa 1991 Salk 1992 ilaa 1993, Caawiye Adjunct Professor, UCSD laga bilaabo 1994 ilaa 1998 bayoloji molecular. Waxa uu hindisay fikradda cusub ee isticmaalka unugyada burooyinka sida nidaamka sii-deynta joogtada ah ee dawooyinka ka hortagga kansarka iyo habka daawaynta ee kaydka sii daynta joogtada ah, kaas oo leh qiime codsi caafimaad, waxa kale oo loo yaqaan jeexjeexa ultro-ugu yar ee kiimikaad ee shakhsi ahaaneed (UMIPIC). 1998-kii, wuxuu ku laabtay Shiinaha wuxuuna aasaasay Machadka Cilmi-baarista Shandong Baofa iyo Isbitaalka Kansarka Taimei Baofa ee Dongping oo ku yaal aagga miyiga ah isagoo maalgashi teknooloji ah, wuxuuna soo noqday guddoomiyaha Shandong Baofa Cancer Treatment Co., LTD., kadibna wuxuu aasaasay Isbitaalka Kansarka Jinan Baofa (2004). Isbitaalka Guud ee Dongping Baofa (2011), Isbitaalka Kansarka ee Beijing Baofa (2013) iyo Immuno Oncology Systems, Inc. UMIPIC-kan waa badbaado, fududahay in la shaqeeyo, waana la soo saari karaa iyadoo faa'iido wanaagsan u leh dhammaan burooyinka adag. Maanta daawayntan waxaa la aqbalayaa "Hagaha Hawlgalka Kiliiniga ee Daaweynta Dhexdhexaadinta ee Kansarka Sare ee Pancreatic" (Trial) (daabacaadda 7aad), oo ay si wadajir ah u sameeyeen Ururka Kansarka Shiinaha ee Ka-hortagga Kansarka, Xarunta Cilmi-baarista Caafimaadka Qaranka ee Radiology iyo Therapy, iyo Isbahaysiga Innovation Medicine Innovation National, Journal of Clinical Radiology, mugga 43,1-20 1.6.
Waxa uu daabacay in ka badan 60 warqadood oo ku saabsan daawaynta ee Dabeecada: Warbixinta Sayniska, Joornaalka Kansarka, J Basic Clin Pharma, J Immunological Sci, Jariirada Jaban ee Gastroenterology iyo Cagaarshowga, Hababka Novel ee Daraasada Kansarka, Journal Academic of Engineering Studies, Nov Res Sci, Journal of Hepatocellular Cancer, Target Journal, Xanuunka Kansarka ee Liverrapy Joornaalka Shiinaha ee Chest,Proc.Natl.Acad.Sci.USA, Pancreas iyo joornaalo kale iyo waraaqo badan oo boosto ah ayaa ka qaybqaatay kulanka AACR iyo ASCO.
Wax ku biirinta ugu weyni waa in daawaynta sii-daynta joogtada ahi ay midayso faa'iidooyinka kiimoterabiga iyo daweynta difaaca jirka, iyo markii ugu horreysay, labada ayaa la isku daray oo lagu dabaqay daawaynta intratumoral iyada oo la faragelinayo. Waxay isku daraysaa daaweynta maxalliga ah iyo kuwa caalamiga ah, waxayna kordhisaa diiradda iyo waqtiga ficilka daroogada iyada oo loo marayo sii-deynta joogtada ah ee daawooyinka gudaha burada, taas oo aan kaliya ka ciyaarin saameynta anticancer maxaliga ah ee daawooyinka kemotherabi, laakiin sidoo kale waxay tixgelisaa doorka immunotherapy nidaamka, sidaas darteed samaynta cilladaha daaweynta kale, bixinta fikrado cusub iyo habab loogu talagalay daaweynta kansarka, gaar ahaan loogu talagalay burooyinka dhexe iyo sare, gaar ahaan hoos u dhigista qiimaha burooyinka Daaweynta UMPIC waxay faa'iido u leedahay isticmaalka burada sida isha antigen-ka iyo tallaalka autologous, kaas oo sidoo kale la jaan qaadaya isbeddelka horumarinta ee Daawada Shakhsi ahaaneed. Oo codsatay rugta caafimaadka, hapten oo ay weheliso dawooyinka kemotherabi ee loogu talagalay daaweynta joogtada ah ee kansarka ganaca, iyada oo la dhalinayo saameyn fog, nuxurka kaas oo ah in la keeno jawaab-celinta difaaca, T-unugyada CD4, CD8, DC, T iyo unugyada NK, iyo B-unugyada la xidhiidha buro autoantibodies: Antibodies to P53, P16, C16, Survival P53, P16, P16, Survivin P53. p62, HCC1 iyo oncogenes kale, tani waa markii ugu horeysay ee la ogaado in T iyo B ay ku lug leeyihiin jawaab celinta difaaca jirka, iyo hawlaha kiliinikada ee saamaynta fog iyo daawaynta this loo doortay "Hagaha Hawlgalka Kiliiniga ee Daaweynta Dhexdhexaadinta ee Kansarka Sare ee Pancreatic" (Trial) (daabacaadda 7aad) si wadajir ah u qaabeeyey by Chinese Anti-Cancer Association iyo Ururka Caafimaadka Qaranka ee Cilmi-baarista Qaranka. Isbahaysiga Innovation Medicine waxaa lagu daabacay Journal of Clinical Radiology, mugga 43, lambarka 19, 2024, 1636-1648.
| Sannadka | Ciwaanka Maqaalka | Daabacaadda |
| 2015 | Saamaynta daawaynta ee la xoojiyey ee marxaladaha hore ee kansarka sanbabada iyada oo la jeexay aadka ugu yar ee shakhsi ahaaneed ee intratumoral | Kansarka Sambabada: Bartilmaameedka iyo Daaweynta, 2015; 6 1-11 |
| 2015 | Ilaalinta sida caadiga ah si loo dilo kansarka | 2015 Qorayaasha. Daawooyinka Kansarka waxaa daabacay John Wiley & Sons Ltd.1349-1403 |
| 2015 | Daciifnimada iyo dhibaatooyinka Isticmaalka Jiirka iyo Jiirka ee Daraasaadka Kahortagga Kansarka | Joornaalka Kansarka 2015; 6 (10): 1058-1065.doi: 10.7150/jca.12519 |
| 2015 | Wakhtiga guud ee badbaadada ee la xoojiyey ee kansarka hepatocellular sare ee loo yaqaan ultra-ugu yar jeexitaan shaqsiyeed chemoimmunotherapy intratumoral | Wargeyska Hepatocellular Carcinoma, 2015: 2, 1-12 |
| 2015 | Isticmaalka dawooyinka Catatonic-ka isku-dhafan ee Hapten si kor loogu qaado Saamaynta Daawaynta ee Marxaladihii Hore ee Kansarka Pancreatic | Joornaalka Cilmi-baarista Beerka, Dhibaatooyinka & Daaweynta, 2015,1(3): 013-23 |
| 2016 | Barashada Muhiimadda Ka Hortagga Isku-beddelka ee Kansarka La Daweyn Karo iyo Burooyinka Wacan | Wargeyska Kansarka 2016; 7 (4): 436-445. doi: 10.7150/jca.13832 |
| 2016 | Hapten Horumaray Guud ahaan Faa'iidada Badbaadinta ee Marxalada danbe ee Kansarka Sambabada Unug Yaryar (NSCLC) ee ay samaysay Jeexitaanka Ugu Yar ee Qofka Intratumoral Chemo Immunotherapy | Joornaalka Kahortagga Kansarka & Cilmi-baarista Hadda 2016, 4(2): 00116 |
| 2020 | A Novel Eclectic Approach for Cancer Therapy with Dareer Mind & Immuno Therapy: UMIPIC, waxa laga yaabaa inay dhaafto Qalliin badan, Chemotherapy iyo Daaweynta Shucaaca ee dhammaan Marxaladihii Buro Adag | Hababka Novel ee Daraasadda Kansarka NACS.000590. 4 (3).2020 |
| 2020 | Dawooyinka Isku-dhafka ah ee H2O2 Intratumoral si loogu beddelo Matrix-ka-ka-baxsan ee Coagulum-ka Autologous sida Kaydka Dawooyinka | Cilmi-baarista Novel ee Sayniska NRS.000584. 4 (2).2020 |
| 2020 | Rajo Cusub oo Daawaynta Kansarka leh Mindida dareeraha ah iyo Daaweyn Immuno: UMIPIC | Isbeddellada Hadda ee Sayniska Caafimaadka & Caafimaadka ISSN:2689-4246 Taariikhda La daabacay: Maarso 20, 2020 |
| 2022 | Caabuqa Burada Ba'an ee leh CD4/8+ iyo CD11+ Wakhtiga Badbaadinta Dheer ee La Wanaajiyey ee Heerarka Sare ee dhammaan Burooyinka Adag ee Jeexitaanka Ugu Yar ee Qofka Intratumoral Chemoimmunotehrapy | Joornaalka Jaban ee Gastroenterology iyo Hepatology |
| 2022 | Caabuqa Ba'an oo leh muujinta Gaarka ah ee CD11 & CD4 Waxay Soo saartaa Saamaynta Abscopal by Cirridka Intramoral Dawooyinka Chemotherapy oo ku dhacay Qaabka Xayawaanka | Joornaalka Sayniska Immunological |
| 2022 | Waa Cusub oo Qalliinka Immuno ah ayaa soo socda: Habka Novel Eclectic ee Daaweynta Kansarka ee Mindida dareeraha ah iyo Daaweynta Immuno | Wargeyska Academic ee Daraasaadka Injineerinka |
| 2022 | Caabuqa Burada Ba'an ee CD4/8+ iyo CD11+ Waxay Dheeraysaa Saamaynta Badbaadinta ee Ay Keentay Duridda Intratumral Isku-dhafka ugu Wanaagsan ee Dawooyinka Chemotherapy iyo Hydralazine sida Ku Dhacday Qaabka Xayawaanka | Joornaalka Jaban ee Gastroenterology iyo Hepatology |
| 2023 | Toosinta Unugyada Difaaca ee Hapten Chemotherapy Intratumoral ee Hapten oo La Kordhiyey Penicillin | Wargeyska Kansarka 2023; 14 (8): 1282-1292 |
| 2023 | Beegsiga guusha leh ee goobta antigen-ka nukliyeerka ee oncogenic ee ay sababto buro la xiriirta autoantibodies (iTAA) | portfolio dabeecadda Warbixinnada Sayniska ee mugga 13, lambarka qodobka: 9902 (2023) |
| 2023 | Isbeddellada Difaaca ee ay keento Intratumoral Hapten Plus Chemotherapy Dawooyinka Kansarka Endometrial | Joornaalka Farmashiyaha Aasaasiga ah iyo Caafimaadka Luulyo 31,2023. DOI: 10.37532/0976-0113.14(S1).17 |
| 2023 | Diyaarinta Immunotherapy Kansarka iyo Dhaqdhaqaaqa Unugyada Difaaca iyada oo loo marayo Dawaynta Chemotherapy ee Hapten-Hapten ee Kansarka Sambabka Hore | Joornaalka Farmashiyaha Aasaasiga ah iyo Caafimaadka Agoosto 11, 2023. DOI: 10.37532/0976-0113.14(S1.18) |
| 2023 | Falanqaynta scRNA-Seq Isbeddellada difaaca ee Intratumoral Hapten Plus Dawooyinka Chemotherapy ee Daaweynta Kansarka Naaska Labka | JURNALKA CILMIGA KANSARKA IYO DAAWAYNTA Kliinikada Noofambar 27, 2023. DOI:10.26502/jcsct.5079214 |
| 2024 | Saamaynta sodium stibogluconate ee qorista iyo kicinta unugyada difaaca ee dareeraha pleural ee kansarka ganaca ee u diyaargarowga immunotherapy | Xuduudaha Immunology Janaayo 19, 2024. DOI: 10.3389/fimmu.2023.1315468 |
| 2024 | Dawaynta Difaaca Kiimikada ee Hapten-Mediated oo leh Maamulka Dawooyinka ee Kansarka ilmo-galeenka iyada oo aan lahayn Hysterectomy | Wargeyska Qalliinka Juun 13, 2024. DOI: 10.29011/2575-9760.11063 |
| 2024 | Isticmaal Profile-SRNA-Seq si aad u qeexdo Jawaabta Immunologic ka dib Buro-gudhuhu Waxay Dhacaan Kiimikada La Wanaajiyey ee Kiis Ku Dhaca Intracranial Anaplastic Hemangiopericytoma Metastasis Beerka: Warbixin Kiis | Wargeyska Qalliinka Juun 10, 2024. DOI: 10.29011/2575-9760.11063 |